市场调查报告书
商品编码
1210920
肛瘘治疗全球市场规模研究和预测:按治疗类型、应用、最终用户、地区划分,2022-2029 年Global Anal Fistula Treatment Market Size study & Forecast, by Treatment Type, by Application, by End-User, and Regional Analysis, 2022-2029 |
肛瘘是一种在肛门和肠道远端之间形成小隧道状结构的病症。
当感染扩散到脓肿形成区域附近时,就会发生这种情况。 脓肿去除后,会形成一个小隧道。 这种情况会引起其他症状,如肠失禁、疼痛、发烧、炎症和疼痛,并且会非常不舒服,因此通常建议手术治疗。 市场增长是由肛瘘的高发病率和復发率以及克罗恩病和溃疡性结肠炎等炎症性肠病 (IBD) 患病率增加等主要因素推动的。
由于克罗恩病和溃疡性结肠炎等炎症性肠病的增加、新产品的推出以及纤维蛋白胶注射和脂肪来源等非手术治疗的普及,肛瘘治疗市场正在迅速扩大干细胞疗法。据预测, 例如,诺丁汉大学的研究人员在 2022 年进行的一项研究发现,该研究由克罗恩病基金会资助,并且出现频率更高。 根据同一项调查,英国每 123 人中就有 1 人患有溃疡性结肠炎或克罗恩病。 这意味着英国约有 500,000 人患有炎症性肠病 (IBD)。 炎症性肠病不是一种非常常见的疾病,但它影响了英国的许多人。 然而,与程序相关的高成本将阻碍整个 2022-2029 年预测期内的市场增长。
研究全球肛瘘治疗市场的主要区域包括亚太地区、北美、欧洲、拉丁美洲和世界其他地区。 由于高公共和私人医疗保健支出以及高炎症性肠病人口,北美被列为最大的创收地区。 然而,由于医疗保健基础设施的改善和医疗保健成本的上升,预计亚太地区将成为增长最快的地区。
这项研究的目的是揭示近年来各个细分市场和国家/地区的市场规模,并预测未来几年的市场规模。 该报告旨在包括被调查国家工业的定性和定量方面。
它还提供了关键方面的详细信息,例如决定市场未来增长的驱动因素和挑战。 此外,它还包含供利益相关者投资的微观市场潜在机会,以及对主要参与者的竞争格局和产品供应的深入分析。
Global Anal Fistula Treatment Market is valued at approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than 3.8% over the forecast period 2022-2029. Anal fistula is a condition in which a tiny, tunnel-like structure forms between the anus and the point where the gut terminates. They arise when an infection spreads nearby to the area where an abscess is developing. After the abscess is removed, a condition develops where a little tunnel forms. Surgery is typically advised as a therapy for this, since the condition may be so uncomfortable, causing bowel incontinence, pain, fever, and other symptoms including irritation and aches and pains. The market growth is driven by key factors such as high incidence rate of anal fistula and recurrence rate and rising cases of Inflammatory Bowel Diseases (IBD) Such As Crohn's Disease and Ulcerative Colitis.
The market for anal fistula treatment is predicted to expand quickly because of the rise in inflammatory bowel disorders including Crohn's disease and ulcerative colitis, the introduction of new products, and the increased popularity of non-surgical treatments like fibrin glue injection and adipose-derived stem cell therapy. For instance, study conducted in 2022 by researchers at the University of Nottingham with funding from Crohn's & Colitis UK and Coeliac UK revealed that Crohn's and Colitis are far more common than initially assumed in the population of the United Kingdom (UK). According to the same survey, 1 in every 123 individuals in the UK suffers from ulcerative colitis or Crohn's disease. In the UK, this leads to a total of roughly 500,000 persons who have inflammatory bowel disease (IBD). Inflammatory bowel disease so affects a large number of people in the UK even though it is not very common. However, high cost associated with the procedure stifles market growth throughout the forecast period of 2022-2029.
The key regions considered for the Global Anal Fistula Treatment Market study include Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is registered as the largest revenue generating region owing to the high public and private healthcare spending as well as the significant number of patients with inflammatory bowel illnesses. However, Asia Pacific is expected to be the fastest growing region due to initiatives to improve healthcare infrastructure and increase in healthcare expenditure.
Major market players included in this report are:
Karl Storz Se & Co. Kg
Cook Medical
Novo Surgical Inc.
Integra LifeSciences
Avante Health Solutions
Advin Health Care
Medtronic plc
Signum Surgical
Angiplast Pvt. Ltd.
Biolitec AG
Recent Developments in the Market:
Global Anal Fistula Treatment Market Report Scope:
Historical Data: 2019-2020-2021
Base Year for Estimation: 2021
Forecast period: 2022-2029
Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered: Treatment type, Application, End-user, Region
Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Treatment Type:
Surgical
Non-Surgical
By Application:
Intersphincteric Fistula
Transsphincteric Fistula
Suprasphincteric Fistula
Others
By End-User:
Hospitals
Ambulatory Surgical Centers
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
RoLA
Rest of the World
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
List of figures
List of tables and figures and dummy in nature, final lists may vary in the final deliverable